An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma

CD4+CD25+Foxp3+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 9; no. 3; p. e91551
Main Authors Tang, Yichen, Xu, Xuejun, Guo, Shixiang, Zhang, Chaobin, Tang, Yan, Tian, Yi, Ni, Bing, Lu, Binfeng, Wang, Huaizhi
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 17.03.2014
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract CD4+CD25+Foxp3+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4+ T cells and CD8+ T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8+ T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4+CD25+Foxp3+ Tregs and CD8+ T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3+ T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3+ T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8+ T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity.
AbstractList CD4+CD25+Foxp3+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4+ T cells and CD8+ T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8+ T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4+CD25+Foxp3+ Tregs and CD8+ T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3+ T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3+ T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8+ T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity.
CD4+CD25+Foxp3+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4+ T cells and CD8+ T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8+ T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4+CD25+Foxp3+ Tregs and CD8+ T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3+ T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3+ T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8+ T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity.CD4+CD25+Foxp3+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4+ T cells and CD8+ T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8+ T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4+CD25+Foxp3+ Tregs and CD8+ T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3+ T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3+ T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8+ T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity.
CD4.sup.+ CD25.sup.+ Foxp3.sup.+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4.sup.+ T cells and CD8.sup.+ T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8.sup.+ T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4.sup.+ CD25.sup.+ Foxp3.sup.+ Tregs and CD8.sup.+ T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3.sup.+ T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3.sup.+ T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8.sup.+ T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity.
CD4 + CD25 + Foxp3 + regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4 + T cells and CD8 + T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8 + T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4 + CD25 + Foxp3 + Tregs and CD8 + T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3 + T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3 + T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8 + T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity.
Audience Academic
Author Tang, Yichen
Zhang, Chaobin
Lu, Binfeng
Xu, Xuejun
Guo, Shixiang
Tang, Yan
Ni, Bing
Wang, Huaizhi
Tian, Yi
AuthorAffiliation 2 Institute of Immunology PLA, Third Military Medical University, Chongqing, China
1 Institute of Hepatopancreatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China
Mie University Graduate School of Medicine, Japan
3 Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
AuthorAffiliation_xml – name: 1 Institute of Hepatopancreatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China
– name: 3 Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, United States of America
– name: Mie University Graduate School of Medicine, Japan
– name: 2 Institute of Immunology PLA, Third Military Medical University, Chongqing, China
Author_xml – sequence: 1
  givenname: Yichen
  surname: Tang
  fullname: Tang, Yichen
– sequence: 2
  givenname: Xuejun
  surname: Xu
  fullname: Xu, Xuejun
– sequence: 3
  givenname: Shixiang
  surname: Guo
  fullname: Guo, Shixiang
– sequence: 4
  givenname: Chaobin
  surname: Zhang
  fullname: Zhang, Chaobin
– sequence: 5
  givenname: Yan
  surname: Tang
  fullname: Tang, Yan
– sequence: 6
  givenname: Yi
  surname: Tian
  fullname: Tian, Yi
– sequence: 7
  givenname: Bing
  surname: Ni
  fullname: Ni, Bing
– sequence: 8
  givenname: Binfeng
  surname: Lu
  fullname: Lu, Binfeng
– sequence: 9
  givenname: Huaizhi
  surname: Wang
  fullname: Wang, Huaizhi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24637664$$D View this record in MEDLINE/PubMed
BookMark eNqNk11v0zAUhiM0xD7gHyCwhITgosVObCfmAqkqX5UmbRqFW8txnNSVa3e2A-x_8INx2m5qpwmhXCQ5ec57cl6fc5odWWdVlj1HcIyKEr1but5bYcbrFB5DyBAh6FF2gliRj2gOi6O95-PsNIQlhKSoKH2SHeeYFiWl-CT7M7FgZqVXIqgGTOreNsJKBVwL5v3K-dHMttpEL6K2HbhSXW9EdP4GzMFUGRPALICp816lcBL4peMCxIUCl951XoWgnQXCNpt364IOg_Kl2FSMWoKPvYzCgEmjrJPCS23dSjzNHrfCBPVsdz_Lvn_-NJ9-HZ1ffJlNJ-cjSVkeR7WoatrSsiCtVBIpBhHL6xyWNa5p1WCkaE2wpLJVbYsRZjVGhWREYIEbUpbFWfZyq7s2LvCdoYEjAitYsQJViZhticaJJV97vRL-hjuh-SbgfMeFT30YxWtIalIhTEiBMRQta0ooB8uJrATDMGl92FXr65VqpLLJVnMgevjF6gXv3E9eMJLOKk8Cb3YC3l33KkS-0kGmUxBWuX7737SkrBo6e3UPfbi7HdWJ1IC2rUt15SDKJ7isSgoZGajxA1S6GrXSMk1fGhB1mPD2ICExUf2OnehD4LNvV__PXvw4ZF_vsQslTFwEZ_qYhiwcgi_2nb6z-HbsE4C3gPQuBK_aOwRBPmzXrV182C6-266U9v5emtRRDOWTI9r8O_kvFbIr5w
CitedBy_id crossref_primary_10_1186_s12979_020_0174_7
crossref_primary_10_1002_jhbp_883
crossref_primary_10_4251_wjgo_v16_i4_1134
crossref_primary_10_1016_j_vetimm_2018_11_008
crossref_primary_10_1158_1078_0432_CCR_23_0258
crossref_primary_10_3390_cancers12082274
crossref_primary_10_3389_fimmu_2022_903564
crossref_primary_10_1016_j_pan_2016_09_007
crossref_primary_10_1136_jitc_2020_000764
crossref_primary_10_1158_2159_8290_CD_19_0094
crossref_primary_10_1097_MD_0000000000037797
crossref_primary_10_1007_s12640_015_9563_7
crossref_primary_10_18632_oncotarget_12772
crossref_primary_10_1016_j_canlet_2017_01_041
crossref_primary_10_1016_j_jcyt_2020_08_001
crossref_primary_10_3389_fgene_2021_702102
crossref_primary_10_1080_2162402X_2015_1102828
crossref_primary_10_1049_syb2_12056
crossref_primary_10_1007_s13277_014_2362_6
crossref_primary_10_1053_j_seminoncol_2021_02_007
crossref_primary_10_1158_1078_0432_CCR_18_0900
crossref_primary_10_3390_cancers12102756
crossref_primary_10_1186_s12935_016_0334_1
crossref_primary_10_3389_fcell_2021_660969
crossref_primary_10_1159_000486581
crossref_primary_10_3389_fimmu_2018_00883
crossref_primary_10_1158_1078_0432_CCR_18_1038
crossref_primary_10_3390_curroncol28060371
crossref_primary_10_1080_2162402X_2022_2066767
crossref_primary_10_1016_j_canlet_2015_11_049
crossref_primary_10_1189_jlb_5VMR1116_493R
crossref_primary_10_1158_2159_8290_CD_19_0958
crossref_primary_10_1016_j_smim_2017_09_002
crossref_primary_10_1080_2162402X_2018_1541535
crossref_primary_10_1016_j_canlet_2022_215694
crossref_primary_10_1371_journal_pone_0106741
crossref_primary_10_3889_oamjms_2021_7639
crossref_primary_10_33160_yam_2019_03_017
crossref_primary_10_3389_fimmu_2017_00829
crossref_primary_10_1007_s00262_015_1775_4
crossref_primary_10_1007_s00106_019_00758_3
crossref_primary_10_1038_onc_2016_458
crossref_primary_10_1038_s41423_021_00742_4
crossref_primary_10_1007_s00428_018_2297_1
crossref_primary_10_3390_cancers13205086
crossref_primary_10_1016_j_bbrc_2015_03_036
crossref_primary_10_3390_cells9020309
crossref_primary_10_3390_curroncol31080316
crossref_primary_10_1042_BSR20192724
crossref_primary_10_1172_jci_insight_152761
crossref_primary_10_1097_PAP_0000000000000161
crossref_primary_10_1158_0008_5472_CAN_22_2589
crossref_primary_10_1186_s12885_021_08770_z
crossref_primary_10_3389_fimmu_2024_1323198
crossref_primary_10_1007_s00277_018_3534_z
crossref_primary_10_3390_cancers13246206
crossref_primary_10_1155_2023_8776892
crossref_primary_10_1186_s12957_021_02420_1
crossref_primary_10_1186_s13046_019_1153_8
crossref_primary_10_3390_cancers14061580
crossref_primary_10_3390_biomedicines9060653
crossref_primary_10_1007_s00268_018_4527_8
crossref_primary_10_1186_s12943_020_01151_3
crossref_primary_10_3390_cancers11010039
crossref_primary_10_3389_fphar_2020_586599
crossref_primary_10_3390_vaccines4030028
crossref_primary_10_3389_fendo_2022_1081585
crossref_primary_10_1111_php_13153
crossref_primary_10_1517_14712598_2015_1000298
crossref_primary_10_3389_fimmu_2022_892543
crossref_primary_10_1136_jitc_2020_000960
crossref_primary_10_3390_cancers14163862
crossref_primary_10_1007_s12032_014_0070_0
crossref_primary_10_1016_j_tranon_2020_100965
crossref_primary_10_1038_s41698_024_00681_z
crossref_primary_10_1016_j_ctarc_2023_100699
crossref_primary_10_3390_cancers11010002
crossref_primary_10_3748_wjg_v21_i31_9297
crossref_primary_10_18632_aging_102917
crossref_primary_10_1080_10408363_2020_1729692
crossref_primary_10_1155_2017_5458178
crossref_primary_10_1155_2017_7979637
crossref_primary_10_3389_fonc_2021_682217
crossref_primary_10_3389_fimmu_2022_876291
crossref_primary_10_62347_CHXD6134
crossref_primary_10_1186_s12943_018_0858_1
crossref_primary_10_1002_JLB_5MR0717_275RR
crossref_primary_10_1016_j_ccell_2022_05_006
crossref_primary_10_1186_s12885_017_3859_3
crossref_primary_10_1155_2019_5981054
crossref_primary_10_1016_j_intimp_2023_109722
crossref_primary_10_18632_oncotarget_20863
crossref_primary_10_3389_fimmu_2017_01900
crossref_primary_10_1007_s00535_023_02020_8
crossref_primary_10_3389_fonc_2020_593452
crossref_primary_10_1038_s41598_019_43992_z
crossref_primary_10_20517_cdr_2023_47
crossref_primary_10_1016_j_celrep_2017_06_062
crossref_primary_10_1007_s00595_018_1728_6
crossref_primary_10_3389_fonc_2019_01359
crossref_primary_10_2217_imt_15_73
crossref_primary_10_1146_annurev_physiol_020518_114515
crossref_primary_10_1186_s13045_022_01322_3
crossref_primary_10_1016_j_ejca_2020_03_013
crossref_primary_10_1016_j_biocel_2016_03_009
crossref_primary_10_1016_j_molmed_2017_03_003
crossref_primary_10_1038_onc_2016_90
crossref_primary_10_3390_cancers13246188
crossref_primary_10_1038_s41568_022_00530_w
crossref_primary_10_1177_11795549241271691
crossref_primary_10_1038_s41423_018_0004_4
crossref_primary_10_3389_fonc_2024_1325575
crossref_primary_10_1136_jitc_2020_001071
crossref_primary_10_1155_2022_8909631
crossref_primary_10_3390_ijms222111378
crossref_primary_10_1038_s41416_022_01927_y
crossref_primary_10_1097_MD_0000000000002266
crossref_primary_10_1186_s12967_016_0812_1
crossref_primary_10_1007_s00428_019_02549_1
crossref_primary_10_1158_1078_0432_CCR_22_1630
crossref_primary_10_1080_2162402X_2016_1175794
crossref_primary_10_1080_21645515_2021_2003645
crossref_primary_10_1016_j_clinbiochem_2016_04_008
crossref_primary_10_1158_2326_6066_CIR_16_0045
crossref_primary_10_3389_fonc_2019_00056
crossref_primary_10_1126_sciadv_adk1827
crossref_primary_10_3390_cancers14040995
crossref_primary_10_1016_j_semcancer_2017_12_009
crossref_primary_10_3390_cancers13194932
crossref_primary_10_18632_oncotarget_2948
crossref_primary_10_3389_fphar_2022_939542
crossref_primary_10_3390_ijms23010254
crossref_primary_10_7717_peerj_8811
crossref_primary_10_1158_0008_5472_CAN_20_2133
crossref_primary_10_2147_RRU_S284066
crossref_primary_10_1097_MD_0000000000005541
crossref_primary_10_1002_cam4_2895
crossref_primary_10_3390_genes12010033
crossref_primary_10_3389_fimmu_2023_1222719
crossref_primary_10_1021_acs_jmedchem_0c00988
crossref_primary_10_1080_2162402X_2025_2451444
crossref_primary_10_2217_imt_2022_0046
crossref_primary_10_3389_fmed_2021_735585
crossref_primary_10_1016_j_molimm_2017_04_012
crossref_primary_10_1016_j_jff_2019_05_006
crossref_primary_10_1073_pnas_1810580115
crossref_primary_10_1007_s00595_019_01817_6
crossref_primary_10_1016_j_oraloncology_2017_02_023
crossref_primary_10_1080_08830185_2017_1363199
crossref_primary_10_3390_cancers14174265
Cites_doi 10.1016/S0039-6060(97)90264-6
10.1016/S0065-2776(06)90002-9
10.1007/s00005-010-0075-0
10.1002/ijc.27784
10.1182/blood-2007-06-094615
10.1084/jem.188.2.287
10.1371/journal.pone.0000129
10.1038/nrgastro.2009.177
10.1038/ni.1774
10.1158/1078-0432.CCR-06-0369
10.1007/s10147-010-0130-1
10.1016/S0065-230X(10)07003-X
10.1136/gutjnl-2011-300970
10.1111/j.1349-7006.2009.01153.x
10.1097/MPA.0b013e3182373a66
10.4049/jimmunol.169.5.2756
10.1038/sj.bjc.6605078
10.1002/ijc.25429
10.1038/bjc.2013.32
10.1371/journal.pone.0080063
10.1158/1078-0432.CCR-06-2363
10.4049/jimmunol.174.5.2591
10.1038/nm1093
10.1038/nri2916
10.1002/ijc.28309
10.1158/1078-0432.CCR-06-2139
10.1084/jem.20102131
10.1002/hep.26013
10.1038/nri1806
10.1007/978-1-59745-409-4_9
10.1007/s00262-008-0603-5
10.1172/JCI31202
10.1111/j.0105-2896.2009.00884.x
10.1182/blood-2004-06-2410
10.3892/etm.2012.553
10.1172/JCI25947
10.1053/j.gastro.2013.07.025
10.1084/jem.20071190
10.1158/0008-5472.CAN-11-0367
10.1159/000342801
10.1084/jem.20042167
10.1158/0008-5472.CAN-07-0175
10.1158/0008-5472.CAN-08-2360
10.1158/1078-0432.CCR-07-5126
ContentType Journal Article
Copyright COPYRIGHT 2014 Public Library of Science
2014 Tang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2014 Tang et al 2014 Tang et al
Copyright_xml – notice: COPYRIGHT 2014 Public Library of Science
– notice: 2014 Tang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2014 Tang et al 2014 Tang et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0091551
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
ProQuest advanced technologies & aerospace journals
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ (Directory of Open Access Journals)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic



Agricultural Science Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Treg Cells Predict the Prognosis of PDA
EISSN 1932-6203
ExternalDocumentID 1508089318
oai_doaj_org_article_b05b5814553440af9d70c00535c8a940
PMC3956642
3248502601
A478760958
24637664
10_1371_journal_pone_0091551
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: NCATS NIH HHS
  grantid: UL1 TR000005
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RNS
RPM
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
PV9
RIG
RZL
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
-
02
AAPBV
ABPTK
ADACO
BBAFP
KM
ID FETCH-LOGICAL-c692t-ba8b6f6735fcec1e90192b207b4b68d41e6b54c6cfeff4149b413c95a4a4d5773
IEDL.DBID M48
ISSN 1932-6203
IngestDate Fri Nov 26 17:22:24 EST 2021
Wed Aug 27 01:30:14 EDT 2025
Thu Aug 21 13:53:54 EDT 2025
Thu Jul 10 23:23:33 EDT 2025
Fri Jul 25 10:19:11 EDT 2025
Tue Jun 17 20:59:35 EDT 2025
Tue Jun 10 20:24:23 EDT 2025
Fri Jun 27 04:18:14 EDT 2025
Fri Jun 27 04:10:13 EDT 2025
Thu May 22 21:19:23 EDT 2025
Thu Apr 03 07:00:51 EDT 2025
Tue Jul 01 02:57:34 EDT 2025
Thu Apr 24 23:04:12 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c692t-ba8b6f6735fcec1e90192b207b4b68d41e6b54c6cfeff4149b413c95a4a4d5773
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
Conceived and designed the experiments: HW BN Yichen Tang BL. Performed the experiments: Yichen Tang XX SG CZ Yan Tang Yi Tian. Analyzed the data: Yichen Tang HW BN BL. Contributed reagents/materials/analysis tools: Yichen Tang XX SG Yan Tang. Wrote the paper: Yichen Tang HW BN BL.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0091551
PMID 24637664
PQID 1508089318
PQPubID 1436336
PageCount e91551
ParticipantIDs plos_journals_1508089318
doaj_primary_oai_doaj_org_article_b05b5814553440af9d70c00535c8a940
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3956642
proquest_miscellaneous_1508676987
proquest_journals_1508089318
gale_infotracmisc_A478760958
gale_infotracacademiconefile_A478760958
gale_incontextgauss_ISR_A478760958
gale_incontextgauss_IOV_A478760958
gale_healthsolutions_A478760958
pubmed_primary_24637664
crossref_primary_10_1371_journal_pone_0091551
crossref_citationtrail_10_1371_journal_pone_0091551
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-03-17
PublicationDateYYYYMMDD 2014-03-17
PublicationDate_xml – month: 03
  year: 2014
  text: 2014-03-17
  day: 17
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2014
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References UK Liyanage (ref39) 2002; 169
DJ Campbell (ref9) 2011; 11
T Yamamoto (ref30) 2012; 41
N Kobayashi (ref10) 2007; 13
YC Lin (ref32) 2013; 132
J Dannull (ref44) 2005; 115
CG Drake (ref8) 2006; 90
ME Lutsiak (ref47) 2005; 105
A Ene-Obong (ref7) 2013; 145
D Mougiakakos (ref16) 2010; 107
TJ Curiel (ref13) 2007; 117
AM Ercolini (ref46) 2005; 201
X Zhou (ref41) 2009; 10
H Ueno (ref3) 2010; 234
CC Preston (ref6) 2013; 8
G Betts (ref22) 2012; 61
S Raimondi (ref1) 2009; 6
KL Ling (ref35) 2007; 7
B Vizio (ref29) 2012; 4
A Pedroza-Gonzalez (ref25) 2011; 208
H Nishikawa (ref17) 2010; 127
B Cambien (ref18) 2009; 100
C Loddenkemper (ref33) 2009; 100
SA Siddiqui (ref20) 2007; 13
R Okita (ref36) 2005; 14
SI Labidi-Galy (ref26) 2011; 71
AM Thornton (ref42) 1998; 188
LC de Rezende (ref43) 2010; 58
DP Kelsen (ref2) 1997; 122
MT Litzinger (ref45) 2007; 110
C Bergmann (ref15) 2008; 14
N Hiraoka (ref27) 2006; 12
Y Ino (ref28) 2013; 108
PA Antony (ref11) 2005; 174
YL Pang (ref23) 2009; 58
CE Clark (ref31) 2007; 67
F Ichihara (ref38) 2003; 9
X Huang (ref14) 2009; 506
Y Huang (ref40) 2012; 86
N Hiraoka (ref4) 2010; 15
A Pedroza-Gonzalez (ref34) 2013; 57
RA Clark (ref19) 2008; 205
TJ Curiel (ref37) 2004; 10
W Zou (ref12) 2006; 6
PJ de Vos van Steenwijk (ref5) 2013; 133
SL Clarke (ref21) 2006; 1
M Gobert (ref24) 2009; 69
20193020 - Immunol Rev. 2010 Mar;234(1):199-212
23891972 - Gastroenterology. 2013 Nov;145(5):1121-32
14555512 - Clin Cancer Res. 2003 Oct 1;9(12):4404-8
15883172 - J Exp Med. 2005 May 16;201(10):1591-602
22907255 - Int J Cancer. 2013 Mar 15;132(6):1341-50
22911397 - Hepatology. 2013 Jan;57(1):183-94
20373146 - Arch Immunol Ther Exp (Warsz). 2010 Jun;58(3):179-90
24244610 - PLoS One. 2013;8(11):e80063
15728465 - J Immunol. 2005 Mar 1;174(5):2591-601
17289884 - Clin Cancer Res. 2007 Feb 1;13(3):902-11
15591121 - Blood. 2005 Apr 1;105(7):2862-8
16211295 - Oncol Rep. 2005 Nov;14(5):1269-73
19244125 - Cancer Res. 2009 Mar 1;69(5):2000-9
18941744 - Cancer Immunol Immunother. 2009 Jun;58(6):877-86
17404089 - Clin Cancer Res. 2007 Apr 1;13(7):2075-81
17388261 - Cancer Immun. 2007;7:7
16730261 - Adv Immunol. 2006;90:51-81
19436305 - Br J Cancer. 2009 Jun 2;100(11):1755-64
23385730 - Br J Cancer. 2013 Mar 5;108(4):914-23
18559587 - Clin Cancer Res. 2008 Jun 15;14(12):3706-15
17616639 - Blood. 2007 Nov 1;110(9):3192-201
19633673 - Nat Immunol. 2009 Sep;10(9):1000-7
20399961 - Adv Cancer Res. 2010;107:57-117
20924634 - Int J Clin Oncol. 2010 Dec;15(6):544-51
17000676 - Clin Cancer Res. 2006 Sep 15;12(18):5423-34
17205133 - PLoS One. 2006;1:e129
22207629 - Gut. 2012 Aug;61(8):1163-71
12193750 - J Immunol. 2002 Sep 1;169(5):2756-61
19806144 - Nat Rev Gastroenterol Hepatol. 2009 Dec;6(12):699-708
18794336 - J Exp Med. 2008 Sep 29;205(10):2221-34
20518016 - Int J Cancer. 2010 Aug 15;127(4):759-67
15322536 - Nat Med. 2004 Sep;10(9):942-9
23060925 - Exp Ther Med. 2012 Jul;4(1):70-78
9225915 - Surgery. 1997 Jul;122(1):53-9
17909062 - Cancer Res. 2007 Oct 1;67(19):9518-27
19110623 - Methods Mol Biol. 2009;506:115-26
17476346 - J Clin Invest. 2007 May;117(5):1167-74
21697280 - Cancer Res. 2011 Aug 15;71(16):5423-34
16557261 - Nat Rev Immunol. 2006 Apr;6(4):295-307
21339324 - J Exp Med. 2011 Mar 14;208(3):479-90
23207161 - Digestion. 2012;86(4):329-37
22158072 - Pancreas. 2012 Apr;41(3):409-15
21267013 - Nat Rev Immunol. 2011 Feb;11(2):119-30
9670041 - J Exp Med. 1998 Jul 20;188(2):287-96
23740735 - Int J Cancer. 2013 Dec 15;133(12):2884-94
16308572 - J Clin Invest. 2005 Dec;115(12):3623-33
19514119 - Cancer Sci. 2009 Jun;100(6):1112-7
References_xml – volume: 122
  start-page: 53
  year: 1997
  ident: ref2
  article-title: Pain as a predictor of outcome in patients with operable pancreatic carcinoma
  publication-title: Surgery
  doi: 10.1016/S0039-6060(97)90264-6
– volume: 90
  start-page: 51
  year: 2006
  ident: ref8
  article-title: Mechanisms of immune evasion by tumors
  publication-title: Adv Immunol
  doi: 10.1016/S0065-2776(06)90002-9
– volume: 58
  start-page: 179
  year: 2010
  ident: ref43
  article-title: Regulatory T cell as a target for cancer therapy
  publication-title: Arch Immunol Ther Exp (Warsz)
  doi: 10.1007/s00005-010-0075-0
– volume: 132
  start-page: 1341
  year: 2013
  ident: ref32
  article-title: Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer
  publication-title: Int J Cancer
  doi: 10.1002/ijc.27784
– volume: 110
  start-page: 3192
  year: 2007
  ident: ref45
  article-title: IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity
  publication-title: Blood
  doi: 10.1182/blood-2007-06-094615
– volume: 188
  start-page: 287
  year: 1998
  ident: ref42
  article-title: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
  publication-title: J Exp Med
  doi: 10.1084/jem.188.2.287
– volume: 1
  start-page: e129
  year: 2006
  ident: ref21
  article-title: CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0000129
– volume: 6
  start-page: 699
  year: 2009
  ident: ref1
  article-title: Epidemiology of pancreatic cancer: an overview
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2009.177
– volume: 10
  start-page: 1000
  year: 2009
  ident: ref41
  article-title: Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo
  publication-title: Nat Immunol
  doi: 10.1038/ni.1774
– volume: 12
  start-page: 5423
  year: 2006
  ident: ref27
  article-title: Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-06-0369
– volume: 15
  start-page: 544
  year: 2010
  ident: ref4
  article-title: Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology
  publication-title: Int J Clin Oncol
  doi: 10.1007/s10147-010-0130-1
– volume: 107
  start-page: 57
  year: 2010
  ident: ref16
  article-title: Regulatory T cells in cancer
  publication-title: Adv Cancer Res
  doi: 10.1016/S0065-230X(10)07003-X
– volume: 61
  start-page: 1163
  year: 2012
  ident: ref22
  article-title: Suppression of tumour-specific CD4(+) T cells by regulatory T cells is associated with progression of human colorectal cancer
  publication-title: Gut
  doi: 10.1136/gutjnl-2011-300970
– volume: 100
  start-page: 1112
  year: 2009
  ident: ref33
  article-title: Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer
  publication-title: Cancer Sci
  doi: 10.1111/j.1349-7006.2009.01153.x
– volume: 41
  start-page: 409
  year: 2012
  ident: ref30
  article-title: Circulating CD4+CD25+ regulatory T cells in patients with pancreatic cancer
  publication-title: Pancreas
  doi: 10.1097/MPA.0b013e3182373a66
– volume: 7
  start-page: 7
  year: 2007
  ident: ref35
  article-title: Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients
  publication-title: Cancer Immun
– volume: 169
  start-page: 2756
  year: 2002
  ident: ref39
  article-title: Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
  publication-title: J Immunol
  doi: 10.4049/jimmunol.169.5.2756
– volume: 100
  start-page: 1755
  year: 2009
  ident: ref18
  article-title: Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6605078
– volume: 9
  start-page: 4404
  year: 2003
  ident: ref38
  article-title: Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers
  publication-title: Clin Cancer Res
– volume: 127
  start-page: 759
  year: 2010
  ident: ref17
  article-title: Regulatory T cells in tumor immunity
  publication-title: Int J Cancer
  doi: 10.1002/ijc.25429
– volume: 108
  start-page: 914
  year: 2013
  ident: ref28
  article-title: Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2013.32
– volume: 14
  start-page: 1269
  year: 2005
  ident: ref36
  article-title: CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer
  publication-title: Oncol Rep
– volume: 8
  start-page: e80063
  year: 2013
  ident: ref6
  article-title: The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(−) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0080063
– volume: 13
  start-page: 902
  year: 2007
  ident: ref10
  article-title: FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-06-2363
– volume: 174
  start-page: 2591
  year: 2005
  ident: ref11
  article-title: CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.174.5.2591
– volume: 10
  start-page: 942
  year: 2004
  ident: ref37
  article-title: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
  publication-title: Nat Med
  doi: 10.1038/nm1093
– volume: 11
  start-page: 119
  year: 2011
  ident: ref9
  article-title: Phenotypical and functional specialization of FOXP3+ regulatory T cells
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2916
– volume: 133
  start-page: 2884
  year: 2013
  ident: ref5
  article-title: Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma
  publication-title: Int J Cancer
  doi: 10.1002/ijc.28309
– volume: 13
  start-page: 2075
  year: 2007
  ident: ref20
  article-title: Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-06-2139
– volume: 208
  start-page: 479
  year: 2011
  ident: ref25
  article-title: Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation
  publication-title: J Exp Med
  doi: 10.1084/jem.20102131
– volume: 57
  start-page: 183
  year: 2013
  ident: ref34
  article-title: Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer
  publication-title: Hepatology
  doi: 10.1002/hep.26013
– volume: 6
  start-page: 295
  year: 2006
  ident: ref12
  article-title: Regulatory T cells, tumour immunity and immunotherapy
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1806
– volume: 506
  start-page: 115
  year: 2009
  ident: ref14
  article-title: DNA transposons for modification of human primary T lymphocytes
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-59745-409-4_9
– volume: 58
  start-page: 877
  year: 2009
  ident: ref23
  article-title: The immunosuppressive tumor microenvironment in hepatocellular carcinoma
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-008-0603-5
– volume: 117
  start-page: 1167
  year: 2007
  ident: ref13
  article-title: Tregs and rethinking cancer immunotherapy
  publication-title: J Clin Invest
  doi: 10.1172/JCI31202
– volume: 234
  start-page: 199
  year: 2010
  ident: ref3
  article-title: Harnessing human dendritic cell subsets for medicine
  publication-title: Immunol Rev
  doi: 10.1111/j.0105-2896.2009.00884.x
– volume: 105
  start-page: 2862
  year: 2005
  ident: ref47
  article-title: Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
  publication-title: Blood
  doi: 10.1182/blood-2004-06-2410
– volume: 4
  start-page: 70
  year: 2012
  ident: ref29
  article-title: Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome
  publication-title: Exp Ther Med
  doi: 10.3892/etm.2012.553
– volume: 115
  start-page: 3623
  year: 2005
  ident: ref44
  article-title: Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
  publication-title: J Clin Invest
  doi: 10.1172/JCI25947
– volume: 145
  start-page: 1121
  year: 2013
  ident: ref7
  article-title: Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2013.07.025
– volume: 205
  start-page: 2221
  year: 2008
  ident: ref19
  article-title: Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells
  publication-title: J Exp Med
  doi: 10.1084/jem.20071190
– volume: 71
  start-page: 5423
  year: 2011
  ident: ref26
  article-title: Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-0367
– volume: 86
  start-page: 329
  year: 2012
  ident: ref40
  article-title: Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients
  publication-title: Digestion
  doi: 10.1159/000342801
– volume: 201
  start-page: 1591
  year: 2005
  ident: ref46
  article-title: Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response
  publication-title: J Exp Med
  doi: 10.1084/jem.20042167
– volume: 67
  start-page: 9518
  year: 2007
  ident: ref31
  article-title: Dynamics of the immune reaction to pancreatic cancer from inception to invasion
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-0175
– volume: 69
  start-page: 2000
  year: 2009
  ident: ref24
  article-title: Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-2360
– volume: 14
  start-page: 3706
  year: 2008
  ident: ref15
  article-title: T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-07-5126
– reference: 23740735 - Int J Cancer. 2013 Dec 15;133(12):2884-94
– reference: 17000676 - Clin Cancer Res. 2006 Sep 15;12(18):5423-34
– reference: 15591121 - Blood. 2005 Apr 1;105(7):2862-8
– reference: 12193750 - J Immunol. 2002 Sep 1;169(5):2756-61
– reference: 20924634 - Int J Clin Oncol. 2010 Dec;15(6):544-51
– reference: 20518016 - Int J Cancer. 2010 Aug 15;127(4):759-67
– reference: 19436305 - Br J Cancer. 2009 Jun 2;100(11):1755-64
– reference: 23207161 - Digestion. 2012;86(4):329-37
– reference: 16211295 - Oncol Rep. 2005 Nov;14(5):1269-73
– reference: 14555512 - Clin Cancer Res. 2003 Oct 1;9(12):4404-8
– reference: 24244610 - PLoS One. 2013;8(11):e80063
– reference: 19806144 - Nat Rev Gastroenterol Hepatol. 2009 Dec;6(12):699-708
– reference: 22158072 - Pancreas. 2012 Apr;41(3):409-15
– reference: 22911397 - Hepatology. 2013 Jan;57(1):183-94
– reference: 18794336 - J Exp Med. 2008 Sep 29;205(10):2221-34
– reference: 19110623 - Methods Mol Biol. 2009;506:115-26
– reference: 17404089 - Clin Cancer Res. 2007 Apr 1;13(7):2075-81
– reference: 9670041 - J Exp Med. 1998 Jul 20;188(2):287-96
– reference: 20193020 - Immunol Rev. 2010 Mar;234(1):199-212
– reference: 17289884 - Clin Cancer Res. 2007 Feb 1;13(3):902-11
– reference: 21267013 - Nat Rev Immunol. 2011 Feb;11(2):119-30
– reference: 15883172 - J Exp Med. 2005 May 16;201(10):1591-602
– reference: 22207629 - Gut. 2012 Aug;61(8):1163-71
– reference: 22907255 - Int J Cancer. 2013 Mar 15;132(6):1341-50
– reference: 16308572 - J Clin Invest. 2005 Dec;115(12):3623-33
– reference: 23891972 - Gastroenterology. 2013 Nov;145(5):1121-32
– reference: 17388261 - Cancer Immun. 2007;7:7
– reference: 18941744 - Cancer Immunol Immunother. 2009 Jun;58(6):877-86
– reference: 23060925 - Exp Ther Med. 2012 Jul;4(1):70-78
– reference: 21697280 - Cancer Res. 2011 Aug 15;71(16):5423-34
– reference: 19633673 - Nat Immunol. 2009 Sep;10(9):1000-7
– reference: 16730261 - Adv Immunol. 2006;90:51-81
– reference: 17476346 - J Clin Invest. 2007 May;117(5):1167-74
– reference: 23385730 - Br J Cancer. 2013 Mar 5;108(4):914-23
– reference: 17909062 - Cancer Res. 2007 Oct 1;67(19):9518-27
– reference: 17205133 - PLoS One. 2006;1:e129
– reference: 16557261 - Nat Rev Immunol. 2006 Apr;6(4):295-307
– reference: 20373146 - Arch Immunol Ther Exp (Warsz). 2010 Jun;58(3):179-90
– reference: 15728465 - J Immunol. 2005 Mar 1;174(5):2591-601
– reference: 21339324 - J Exp Med. 2011 Mar 14;208(3):479-90
– reference: 19244125 - Cancer Res. 2009 Mar 1;69(5):2000-9
– reference: 15322536 - Nat Med. 2004 Sep;10(9):942-9
– reference: 18559587 - Clin Cancer Res. 2008 Jun 15;14(12):3706-15
– reference: 19514119 - Cancer Sci. 2009 Jun;100(6):1112-7
– reference: 20399961 - Adv Cancer Res. 2010;107:57-117
– reference: 9225915 - Surgery. 1997 Jul;122(1):53-9
– reference: 17616639 - Blood. 2007 Nov 1;110(9):3192-201
SSID ssj0053866
Score 2.5247567
Snippet CD4+CD25+Foxp3+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood...
CD4.sup.+ CD25.sup.+ Foxp3.sup.+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the...
CD4 + CD25 + Foxp3 + regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e91551
SubjectTerms Abundance
Adenocarcinoma
Adult
Aged
Antigens
Biology and Life Sciences
Cancer therapies
Carcinoma, Pancreatic Ductal - immunology
Carcinoma, Pancreatic Ductal - mortality
Carcinoma, Pancreatic Ductal - pathology
Case-Control Studies
CD25 antigen
CD4 antigen
CD8 antigen
CD8-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - metabolism
Colorectal cancer
Comparative analysis
Correlation
Cytokines
Cytometry
Cytotoxicity
Disease Progression
Epithelial cells
Female
Flow cytometry
Forkhead Transcription Factors - metabolism
Foxp3 protein
Hospitals
Humans
Immunity
Immunology
Immunophenotyping
Immunoregulation
Immunosuppression
Immunotherapy
Leukocytes (mononuclear)
Liver cancer
Lymphocyte Count
Lymphocytes
Lymphocytes T
Lymphocytes, Tumor-Infiltrating - immunology
Lymphocytes, Tumor-Infiltrating - metabolism
Male
Medical prognosis
Medical research
Medicine and Health Sciences
Middle Aged
Neoplasm Grading
Neoplasm Metastasis
Neoplasm Staging
Ovarian cancer
Pancreas
Pancreatic cancer
Pancreatic Neoplasms - immunology
Pancreatic Neoplasms - mortality
Pancreatic Neoplasms - pathology
Patients
Peripheral blood mononuclear cells
Prognosis
Research and Analysis Methods
Stroma
Studies
Surgery
T cells
T-Lymphocyte Subsets - immunology
T-Lymphocyte Subsets - metabolism
T-Lymphocytes, Regulatory - immunology
T-Lymphocytes, Regulatory - metabolism
Tissues
Tumor Microenvironment
Tumors
SummonAdditionalLinks – databaseName: DOAJ (Directory of Open Access Journals)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquBAgYhAYe0eTi2c1wQVUECJGhRb5HtOGWlrbPa7B74H_xgZmxv1KBK5cAx8cRKZsbziMffEPJKtCoHt8NT7IuUMpPzVBZapgp0pZTaKum3Cz5_4Sdn7NN5dX6l1RfWhAV44MC4I51VupIIp10ylqmubkVmPCqJkapmPlsHn7dLpoINhlXMeTwoV4r8KMrlcNU7ewhRBcYJE0fk8fpHqzxbLfvhupDz78rJK67o-C65E2NIOg_vvkduWXeP7MVVOtA3EUr67X3ye-7owmFgONiWKo3HPoCG9h3dbC_7dQr6tVh65Fx3QdehL32__kVPKf7RH-hioAb7d8BtmAB_2lKIGKmv6gqIHlS51l-7fgBqmBnsSwhFDUUwWXhTBcYNfObaLFx_qR6Qs-MPp-9P0tiHITW8LjapVlLzjouy6ow1ua0xLNRFJjTTXLYst1xXzHDT2a5jkHJp8IymrhRTrK2EKB-SmQPO7xNaFzLv8lK2RW5Y3RZ1ZnEjUnW6VqXOdELKnVAaE0HKsVfGsvE7bwKSlcDjBkXZRFEmJB2fWgWQjhvo36G8R1qE2PY3QPGaqHjNTYqXkOeoLU04rzoaimaOcEcI4ycT8tJTIMyGwzqeC7Udhubj1x__QPT924TodSTqemCHUfHsBHwTwndNKA8mlGAszGR4H3V7x5WhwXYAGcSsOT650_frh1-Mwzgp1uY5228DDRZKS5GQR2F5jJwtGAcPxllCxGThTFg_HXGLnx7lvITMHZLjx_9DVk_IbQh0GdYO5uKAzDbrrX0KweRGP_N24w9BrHOJ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELagXLggltcGFjAICThkNw_HcU6oFMoWCVgtXbS3yHacUinrlKY98D_4wcwkbiBoBRxjT6xkxvOwPf6GkGdpIUNwO9zHukg-0yH3RaSEL2GuxEIZKdrjgg8f-fEZe3-enLsNt8alVe5sYmuoi1rjHvkR4pYH4FxD8Wr1zceqUXi66kpoXCXXQvA0mNIlpu92lhh0mXN3XS5OwyMnncNVbc0hxBYYLQzcUYva39vm0aqqm8sCzz_zJ39zSNOb5IaLJOm4E_0euWLsLbLndLWhLxyg9Mvb5MfYUrADmH5uCjpWePkDaGhd0vn2ol77M1suqxY_1y7oaVedvl5_p3M6MVXV0FlDJ1jFA5phANy6pRA30hPM7epwPai0Rfts62bZ4Mgn0nYBqaZvtnqDXwomDjznWi9tfSHvkLPp2_nk2HfVGHzNs2jjKykUL3kaJ6U2OjQZBocqClLFFBcFCw1XCdNcl6YsGSy8FPhHnSWSSVYkaRrfJSMLnN8nNItEWIaxKKJQs6yIssDgcaQsVSZjFSiPxDuh5NpBlWPFjCpvz99SWLJ0PM5RlLkTpUf8_q1VB9XxD_rXKO-eFoG224Z6vcid3uYqSFQiEM09ZiyQZVakgW5BcbSQGQs88hhnS97dWu3NRT5G0CME8xMeedpSINiGxWyehdw2TT779OU_iD6fDoieO6KyBnZo6W5QwD8hiNeA8mBACSZDD7r3cW7vuNLkv5QL3tzN98u7n_TdOChm6FlTbzsaTJcWqUfuderRczZiHPwYZx5JB4ozYP2wxy6_tljnMazfYYl8_--f9YBch0CWYW5gmB6Q0Wa9NQ8hWNyoR61F-AkG_2rv
  priority: 102
  providerName: ProQuest
Title An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma
URI https://www.ncbi.nlm.nih.gov/pubmed/24637664
https://www.proquest.com/docview/1508089318
https://www.proquest.com/docview/1508676987
https://pubmed.ncbi.nlm.nih.gov/PMC3956642
https://doaj.org/article/b05b5814553440af9d70c00535c8a940
http://dx.doi.org/10.1371/journal.pone.0091551
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELb6uHBBlFcDZTEICThklWwc2zkgtF22tEgtVemi3iLbScpKqbNsdiV64Vfwg5nJSwQVgbhY2nhsZceeVzz-hpAXIlE-mB3uYl0klxmfu3KkpatgrwRSp0pWxwXHJ_xwxj5chBcbpK3Z2jCwvDG0w3pSs2U-_Pb1-i0I_JuqaoPw20HDRWHTIfgM6AVskm2wTQJrGhyz7lwBpJvz5gLdn0YiPDDjIHec9WxVBenfKe6tRV6UN3mlvydX_mKtDu6Q242bScf1vtghG6m9S3YaQS7pqwZt-vU98mNsKSgJzE1PEzrWeDMEaGiR0fP1VbF0j2w2zytwXXtJz-rS9cXymp7TSZrnJT0q6QRLfMBjmAC_61JwKukpJn7VoB9U2aT6bYtyXuLMp8rW3qqh79ZmhW8K-g_M6tLMbXGl7pPZwfR8cug2pRpcw6PRytVKap5xEYSZSY2fRug56pEnNNNcJsxPuQ6Z4SZLs4xBVKbBeJooVEyxJBQieEC2LCzCLqHRSPqZH8hk5BsWJaPIS_GsUmU6UoH2tEOCdlFi0-CYYzmNPK4O5wTEMzWPY1zVuFlVh7jdqEWN4_EX-n1c744WUbirB8XyMm6EOtZeqEOJUO8BY57KokR4pkLMMVJFzHPIU9wtcX2ltdMl8RgRkRDpTzrkeUWBSBwWU30u1bos46OPn_-B6NNZj-hlQ5QVwA6jmusV8J8Q4atHudejBH1iet27uLdbrpQxVgzwwK31cWS732_uftZ146SYvmfTYl3TYC61FA55WItHx9lW2BwieoLTY32_x86_VEDoAQT3ED8_-u-Rj8ktcIAZ5hT6Yo9srZbr9Ak4mSs9IJviQkArJz62B-8HZHt_enJ6Nqg-2wwqvYLt9-lP6x2Ecg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lc9MwENaUcIALQ3k1UKhgYICDWz9kWT4wTEgpDX3QKSnTm5FkOWQmlUOcDNP_we_gN7LrR8BMB7j0GGutcbTrb1fW7reEPI1S6YHb4Q72RXKY9rgjfCUcCbYSCGWkKI8LDg757gl7fxqerpAfTS0MplU2mFgCdZpr_Ea-hbzlLjhXT7yefnWwaxSerjYtNCqz2DPn32DLVrwabIN-n_n-ztthf9epuwo4msf-3FFSKJ7xKAgzbbRnYgxylO9GiikuUuYZrkKmuc5MljHYQCjAeR2HkkmWhlEUwLxXyFUWgCfHyvSddw3yA3ZwXpfnBZG3VVvD5jS3ZhNiGYxOWu6v7BKw9AWd6SQvLgp0_8zX_M0B7twkN-rIlfYqU1slK8beIqs1NhT0RU1g_fI2-d6zFHAH091NSnsKi01AhuYZHS7O8pkzsNl4UvL12hE9NiNsIZbPzumQ9s1kUtBBQfvYNQQuwwT4qZhCnEqPMJes4hGh0qblb5sX4wJnPpK2CoA13V7oOT4pQCp46pke2_xM3iEnl6Knu6RjYeXXCI194WVeIFLf0yxO_dg1ePwpMxXLQLmqS4JGKYmuqdGxQ8ckKc_7ItgiVWucoCqTWpVd4izvmlbUIP-Qf4P6XsoisXd5IZ-NkhonEuWGKhTIHh8w5sosTiNXlyQ8WsiYuV2ygdaSVFWyS3hKekiyhOSBokuelBJI7mExe2gkF0WRDD58-g-hj8ctoee1UJbDcmhZV2zAf0LSsJbkeksSIEq3htfQtptVKZJfLzPc2dj7xcOPl8M4KWYEWpMvKhlMzxZRl9yrXo_lyvqMg9_krEui1ovTWvr2iB1_KbnVgxj2N8y___fH2iDXdocH-8n-4HDvAbkOQTTDvEQvWied-WxhHkKgOlePSnSg5PNlw9FP9hKocQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKkRAXRPnrQqEGgYBD2vw4tnNAaNlSdSmUqrSot2A7zrLS1lk2u0J9D56Gp2MmyQaCKuDCMfHESsbjb8bx-BtCHotMBeB2uId1kTxmAu7JUEtPga1EUlslq-2Cdwd874S9OY1PV8j35VkYTKtcYmIF1Flh8B_5NvKW--BcA7mdN2kRhzu7L6dfPKwghTuty3IatYns2_OvsHwrXwx3YKyfhOHu6-PBntdUGPAMT8K5p5XUPOciinNjTWATDHh06AvNNJcZCyzXMTPc5DbPGSwmNGC-SWLFFMtiISLo9xK5LCIhcY7JQZteAjjCeXNULxLBdmMZW9PC2S2IazBS6bjCqmJA6xdWp5OivCjo_T138xdnuHudXGuiWNqvzW6NrFh3g6w1OFHSZw2Z9fOb5FvfUcAgTH23Ge1rPHgCMrTI6fHirJh5Q5ePJxV3rxvRIzvCcmLF7Jwe04GdTEo6LOkAK4jAbegAfxtTiFnpIeaV1ZwiVLmsunZFOS6x50Pl6mDY0J2FmeObAryC156ZsSvO1C1y8l_G6TZZdaD5dUKTUAZ5EMksDAxLsjDxLW6FqlwnKtK-7pFoOSipaWjSsVrHJK32_gQsl2odpziUaTOUPeK1T01rmpC_yL_C8W5lkeS7ulHMRmmDGan2Yx1LZJKPGPNVnmTCNxUhj5EqYX6PbKK1pPWJ2Raq0j4SLiGRoOyRR5UEEn04nDIjtSjLdPj-4z8IfTjqCD1thPIC1GFUc3oDvgkJxDqSGx1JgCvTaV5H215qpUx_Tmx4cmnvFzc_bJuxU8wOdLZY1DKYqi1Fj9ypp0er2ZBx8KGc9YjoTJyO6rstbvy54lmPEljrsPDun19rk1wBIErfDg_275GrEE8zTFEMxAZZnc8W9j7ErHP9oAIHSj79bzT6AUKyrHI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+Increased+Abundance+of+Tumor-Infiltrating+Regulatory+T+Cells+Is+Correlated+with+the+Progression+and+Prognosis+of+Pancreatic+Ductal+Adenocarcinoma&rft.jtitle=PloS+one&rft.au=Tang%2C+Yichen&rft.au=Xu%2C+Xuejun&rft.au=Guo%2C+Shixiang&rft.au=Zhang%2C+Chaobin&rft.date=2014-03-17&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=9&rft.issue=3&rft_id=info:doi/10.1371%2Fjournal.pone.0091551&rft_id=info%3Apmid%2F24637664&rft.externalDocID=PMC3956642
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon